Letter by Fan and He Regarding Article, “Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Disease and Abnormal Fractional Flow Reserve” | Zendy

Guoxin Fan | Zendy; Junbo Ge | Zendy; Shisheng He | Zendy

Open Access

Letter by Fan and He Regarding Article, “Cost-Effectiveness of Percutaneous Coronary Intervention in Patients With Stable Coronary Disease and Abnormal Fractional Flow Reserve”

Author(s) -

Guoxin Fan,

Junbo Ge,

Shisheng He

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.005859

Subject(s) - fractional flow reserve , medicine , percutaneous coronary intervention , coronary artery disease , cardiology , china , angina , coronary angiography , myocardial infarction , law , political science

We take great interest in the article by Fearon et al1 with regard to the economic and quality of life implications of percutaneous coronary intervention among patients with stable angina. The study assessed patient utility with the use of the EQ-5D health survey in the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 2 (FAME 2) trial and found that percutaneous coronary intervention of coronary lesions with abnormal fractional flow reserve was more economically attractive than best medical therapy. However, we have some concerns with the statistical analysis.Cost–utility analysis is a common comparative effectiveness methodology in current health economics research, and quality-adjusted life-year …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research